Q3 Results 2025: Swiggy loss widens to Rs 799.08 crore; Kansai Nerolac Paints profit jumps over 3x

Patanjali Keswani, Chairman & Managing Director, Lemon Tree Hotels Limited, said, “Lemon Tree recorded its highest-ever third-quarter revenue this year. At Rs 355.8 crore, our revenue grew by 22% compared to Q3 last year, while Net EBITDA grew 30% Y-o-Y to Rs 184.8 crore, translating into a Net EBITDA Margin of 51.9%, which increased by 316 bps Y-o-Y. Q3 FY25 recorded a Gross ARR of Rs 6,763, which increased by 7% Y-o-Y. The occupancy for the quarter stood at 74.2%, an increase of 826 bps Y-o-Y. This translated into a RevPAR of Rs 5,018, which increased by 21% Y-o-Y. Fees from management and franchised contracts for third-party-owned hotels stood at Rs 18.4 crore in Q3 FY25, an increase of 24% Y-o-Y. Fees from Fleur Hotels stood at Rs 25.3 crore in Q3 FY25, an increase of 45% Y-o-Y. Total management fees for Lemon Tree stood at Rs 43.7 crore in Q3 FY25, an increase of 35% Y-o-Y.

As of December 31, 2024, the inventory for the group stands at 112 operational hotels with 10,317 rooms and a pipeline of 88 hotels with 6,068 rooms.”

Lemon Tree Hotels Ltd released its fiscal third quarter earnings report with profit at Rs 62.49 crore, posting a jump of 76.53 per cent in comparison to Rs 35.40 crore during the corresponding quarter of FY24. It posted revenue from operations at Rs 355.18 crore, up 22.40 per cent as against Rs 290.18 crore during the same period of previous financial year. The company EBITDA stood at Rs 184.2 crore, up 30.5 per cent YoY.

Surendran Chemmenkotil, Chief Executive Officer, Metropolis Healthcare Limited, said, “We have achieved double-digit growth for the third consecutive quarter, despite a traditionally challenging Q3 with lower illness-driven demand. This success stems from our focus on key segments, TruHealth and Specialty, and our efforts to drive regional growth through targeted micro-marketing strategies and deeper market penetration. Through TruHealth™ packages, we have been able to enhance the customer experience by integrating home-based ECG services, vital checks, and consultations. Additionally, the introduction of the AI-powered MetAdvisor recommendation engine further personalises care by analysing historical data and test combinations.”

Ameera Shah, Executive Chairperson & Whole-time Director, Metropolis Healthcare Limited, said, “The diagnostics industry is undergoing a paradigm shift towards personalized medicine, genomics-driven testing, and preventive healthcare, fueled by advancements in molecular diagnostics, AI, and next generation sequencing. At Metropolis, we remain at the forefront of this transformation, leveraging deep scientific expertise and consumer insights to drive innovation and expand access to cutting-edge diagnostics. Our strategic acquisition of Core Diagnostics is a pivotal step in this direction, strengthening our oncology and molecular diagnostics portfolio and reinforcing our commitment to becoming India’s leading cancer testing provider. As part of our long-term strategy, we are expanding our presence in North India through a ‘string of pearls’ approach, focusing on acquiring high-performing B2C businesses that are leaders in their cities, with strong EBITDA, ROCE, and cash flows.”

• Strong B2C revenue growth at 15% YoY in Q3FY25; Patient volume grew by 5%, with a robust 10% increase in RPP (Revenue Per Patient), enabled by enhanced upselling and value delivery.

• B2B revenue grew 10% YoY in Q3FY25 – consistent double -digit growth, third quarter in a row.

• TruHealth revenue grew 25% YoY, with its contribution rising from 14% in Q3FY24 to 17% in Q3FY25.

• Specialty revenue grew 13% YoY, driven by a focus on specialized, non-seasonal tests.

• Reported EBITDA and PAT Margins for Q3FY25 stood at 22.2% and 9.8% respectively.

Metropolis Healthcare Ltd released its fiscal third quarter earnings report with profit at Rs 31.36 crore, posting a growth of 15.46 per cent in comparison to Rs 27.16 crore during the corresponding quarter of FY24. It posted revenue from operations at Rs 322.77 crore, up 10.87 per cent as against Rs 291.12 crore during the same period of previous financial year. The company EBITDA stood at Rs 72 crore, up 9.4 per cent YoY.

Elara Securities said, “KPR Mill’s (KPR IN) Q3 performance was a miss on revenue, EBITDA and PAT by 5.5%, 13.1% and 10.1% YoY respectively. The subdued sugar segment hit overall profitability, led by an EBIT decline of 64.4% to Rs 188mn. This was offset by strong performance in the textiles segment, led by higher volumes in both yarn and garments and improved YoY profitability. Adjusting for textile and sugar segment’s volumes in Q3 performance and assuming higher garment capex in FY27 (against FY26 earlier), we slightly pare FY25E, FY26E and FY27E earnings estimates by 0.6%, 1.6% and 1.8%, respectively. We maintain our positive stance as KPR is a strong play on India’s garment export theme with a robust balance sheet.”

JM Financial said, “Tata Power (TPWR) reported Q3FY25 net consol revenue of Rs 154bn (5% YoY, 0% JMFe) and EBITDA of Rs 31bn (18% YoY, -6% JMFe) led by regulatory upside in Mundra. Adj. PAT came in at Rs 10bn (8% YoY, -5% JMFe). The company is well positioned for upside in performance with traction in transmission (2,414 Ckm under construction), distribution (20% revenue CAGR FY22-24 in Odisha DISCOMs), renewable (10 GW pipeline, 4 GW Cell & module operational) business and pumped hydro storage (2.8 GW) involving a CapEx of INR 200bn in FY25 (Rs 120 bn spent in 9M).”

Motilal Oswal Financial Services said, “Its consolidated/standalone revenue declined 6%/8% YoY (in line). Domestic volume inched up 1.6% YoY. Weak industry demand, downtrading, a subdued festive season, and rising competition adversely impacted the growth. The impact of last year’s price cuts (3%) continued to drag value growth despite a 1% price hike in Q2FY25. The decorative paints industry saw a 4-5% decline in Q3. International business delivered 5% revenue growth (17% in CC terms). We remain cautious about both value growth and margin for FY26. Despite a correction in the stock, demand and competitive pressures still hover around earnings.”

Today, several companies including Swiggy, Info Edge India, Reliance Power, Zydus Lifesciences, Cummins India, Abbott India, Page Industries, Kansai Nerolac Paints, Gujarat Gas, Welspun Corp, Eveready Industries, Arvind Fashions, Skipper, Mrs Bectors Food Specialities, Symphony, Nilkamal, and others are lined up to announce their Q3 numbers.

Greetings! With the quarter earnings season in full swing, we, at FinancialExpress.com, are continuously bringing to you all the updates and all important numbers being announced by companies across sectors. We will also analyse these results with the help of brokerage firms and analysts. Stay tuned.